Literature DB >> 2149064

Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. III. Analysis of regulatory cells suppressing the induction of thyroiditis.

S Sugihara1, S Maruo, T Tsujimura, O Tarutani, Y Kohno, T Hamaoka, H Fujiwara.   

Abstract

It has previously been demonstrated that T cell clones with potentials to induce autoimmune thyroiditis exist in lymphoid organs from normal healthy individuals. The present study investigates the nature of regulatory cells co-existing in a normal lymphoid cell population to prevent the activation of these thyroiditis-inducing T cells. T cell-depleted (C57BL/6 x C3H/He) F1 mice (B cell mice) were prepared by adult thymectomy and injection of anti-thymocyte serum, followed by lethal X-irradiation and bone marrow reconstitution. Typical thyroiditis was induced in these B cell mice by i.v. administration of Lyt-1dull T cells but not of whole T cells from normal syngeneic mice. Additional injection of normal thymocytes into B cell mice which had been transferred with the Lyt-1 dull T cells resulted in complete prevention of thyroiditis induction. Mature thymocytes were responsible for this regulatory function and such regulatory cell activity was also found in peripheral lymphoid cells such as spleen cells. These regulatory cells exerted their capacity to prevent thyroiditis in cell dose-dependent and injection timing-dependent manners; thyroiditis was prevented when they were injected in cell doses of greater than 1.5 x 10(7)/mouse and before the initiation of the thyroiditis lesion. Most interestingly, the phenotypes of regulatory cells were Thy-1+ and L3T4+. Since the thyroiditis-inducing Lyt-1 dull T cells has previously been shown to be of L3T4+, these results indicate that there exist functionally heterogeneous subsets in an L3T4+ T cell population and that some L3T4+ T cells function as regulatory cells to prevent the activation of thyroiditis-inducing L3T4+ T cells co-existing in the normal lymphoid cell population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149064     DOI: 10.1093/intimm/2.4.343

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Authors:  E Uchio; M Kijima; M Ishioka; S Tanaka; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

2.  T-cell receptor V beta repertoire of L3T4+ regulatory T cells in anti-L3T4 antibody-induced tolerant NOD mice.

Authors:  A Sakamoto; M Furukawa; I Iwamoto; T Koike; H Tomioka; T Sumida
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

3.  Suppression of efferent limb of testicular autoimmune response by a regulatory CD4+ T cell line in mice.

Authors:  M Itoh; A Mukasa; Y Tokunaga; C Hiramine; K Hojo
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

4.  Thyroid hypofunction related with the progression of human immunodeficiency virus infection.

Authors:  A Olivieri; M Sorcini; P Battisti; C Fazzini; E Gilardi; Y Sun; E Medda; M Grandolfo; G Tossini; S Natili
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

5.  OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset.

Authors:  F Powrie; D Mason
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

6.  Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).

Authors:  V Kumar; K Stellrecht; E Sercarz
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential.

Authors:  D Fowell; D Mason
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.